Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2001 Aug;85(8):962–968. doi: 10.1136/bjo.85.8.962

A 7 year prospective comparative study of three topical β blockers in the management of primary open angle glaucoma

P Watson 1, M Barnett 1, V Parker 1, J Haybittle 1
PMCID: PMC1724066  PMID: 11466256

Abstract

AIM—To determine the long term efficacy of monotherapy with topically applied β blocking agents and to determine whether selective β blockers were able to preserve the visual field more effectively than non-selective agents.
METHOD—A prospective randomised, open, comparative study of three topically applied β blockers—timolol, betaxolol, and carteolol—was carried out on 153 patients (280 eyes) with newly diagnosed open angle glaucoma. Those patients who were not withdrawn were followed by the same observers for a minimum of 2 years and a maximum of 7 years, with clinical observations, Goldmann tonometry and 24.2 Humphrey visual field analysis.
RESULTS—All three drugs lowered the IOP significantly from untreated levels but betaxolol took up to 12 months in some instances to reach the maximum pressure reduction. After 7 years only 43% of the eyes begun on timolol, 34% of those started on carteolol, and 29% of those on betaxolol were still being treated with these medications alone. Visual fields were analysed throughout the trial by CPSD and MD and at the end by linear regression analysis (PROGRESSOR). The visual fields remained the same without apparent improvement or deterioration throughout the period of follow up. Eight patients (11 eyes) were withdrawn because of continuing field loss in spite of reduction in IOP (six using carteolol and five using betaxolol).
CONCLUSIONS—Analysis shows that less than half the eyes initially treated with topical β blockers might be expected to still be being treated with their original medication after 5 years. The rest required either additional medication or trabeculectomy. There was no statistically significant improvement or deterioration in the visual fields over a 7 year period. On the evidence of this trial there are no particular advantages in using selective β blockers.



Full Text

The Full Text of this article is available as a PDF (167.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. C., Hertzmark E., Walker A. M., Epstein D. L. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am J Ophthalmol. 1986 May 15;101(5):535–541. doi: 10.1016/0002-9394(86)90942-6. [DOI] [PubMed] [Google Scholar]
  2. Armaly M. F., Krueger D. E., Maunder L., Becker B., Hetherington J., Jr, Kolker A. E., Levene R. Z., Maumenee A. E., Pollack I. P., Shaffer R. N. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 1980 Dec;98(12):2163–2171. doi: 10.1001/archopht.1980.01020041015002. [DOI] [PubMed] [Google Scholar]
  3. Armaly M. F., Sayegh R. E. The cup-disc ratio. The findings of tonometry and tonography in the normal eye. Arch Ophthalmol. 1969 Aug;82(2):191–196. doi: 10.1001/archopht.1969.00990020193008. [DOI] [PubMed] [Google Scholar]
  4. Collignon-Brach J. Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma. Curr Eye Res. 1992 Jan;11(1):1–3. doi: 10.3109/02713689209069161. [DOI] [PubMed] [Google Scholar]
  5. Denis P., Elena P. P. Récepteurs bêta-adrénergiques vasculaires rétiniens chez l'homme. Ophtalmologie. 1989 Jan-Mar;3(1):62–64. [PubMed] [Google Scholar]
  6. Drance S. M. A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. J Glaucoma. 1998 Aug;7(4):247–252. doi: 10.1097/00061198-199808000-00006. [DOI] [PubMed] [Google Scholar]
  7. Epstein D. L., Krug J. H., Jr, Hertzmark E., Remis L. L., Edelstein D. J. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989 Oct;96(10):1460–1467. doi: 10.1016/s0161-6420(89)32688-1. [DOI] [PubMed] [Google Scholar]
  8. Galassi F., Nuzzaci G., Sodi A., Casi P., Cappelli S., Vielmo A. Possible correlations of ocular blood flow parameters with intraocular pressure and visual-field alterations in glaucoma: a study by means of color Doppler imaging. Ophthalmologica. 1994;208(6):304–308. doi: 10.1159/000310526. [DOI] [PubMed] [Google Scholar]
  9. Grajewski A. L., Ferrari-Dileo G., Feuer W. J., Anderson D. R. Beta-adrenergic responsiveness of choroidal vasculature. Ophthalmology. 1991 Jun;98(6):989–995. doi: 10.1016/s0161-6420(91)32216-4. [DOI] [PubMed] [Google Scholar]
  10. Jay J. L., Murdoch J. R. The rate of visual field loss in untreated primary open angle glaucoma. Br J Ophthalmol. 1993 Mar;77(3):176–178. doi: 10.1136/bjo.77.3.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kass M. A., Gordon M. O., Hoff M. R., Parkinson J. M., Kolker A. E., Hart W. M., Jr, Becker B. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol. 1989 Nov;107(11):1590–1598. doi: 10.1001/archopht.1989.01070020668025. [DOI] [PubMed] [Google Scholar]
  12. Mao L. K., Stewart W. C., Shields M. B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 1991 Jan 15;111(1):51–55. doi: 10.1016/s0002-9394(14)76896-5. [DOI] [PubMed] [Google Scholar]
  13. Martin L., Wanger P. Five-year follow-up of treated patients with glaucoma using resolution perimetry. J Glaucoma. 1998 Feb;7(1):22–26. [PubMed] [Google Scholar]
  14. Messmer C., Flammer J., Stümpfig D. Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am J Ophthalmol. 1991 Dec 15;112(6):678–681. doi: 10.1016/s0002-9394(14)77274-5. [DOI] [PubMed] [Google Scholar]
  15. Schulzer M., Drance S. M., Douglas G. R. A comparison of treated and untreated glaucoma suspects. Ophthalmology. 1991 Mar;98(3):301–307. doi: 10.1016/s0161-6420(91)32296-6. [DOI] [PubMed] [Google Scholar]
  16. Sorensen S. J., Abel S. R. Comparison of the ocular beta-blockers. Ann Pharmacother. 1996 Jan;30(1):43–54. doi: 10.1177/106002809603000109. [DOI] [PubMed] [Google Scholar]
  17. Sponsel W. E., Kaufman P. L., Blum F. G., Jr Association of retinal capillary perfusion with visual status during chronic glaucoma therapy. Ophthalmology. 1997 Jun;104(6):1026–1032. doi: 10.1016/s0161-6420(97)30191-2. [DOI] [PubMed] [Google Scholar]
  18. Stewart R. H., Kimbrough R. L., Ward R. L. Betaxolol vs timolol. A six-month double-blind comparison. Arch Ophthalmol. 1986 Jan;104(1):46–48. doi: 10.1001/archopht.1986.01050130056019. [DOI] [PubMed] [Google Scholar]
  19. Stewart W. C., Chorak R. P., Hunt H. H., Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993 Aug 15;116(2):176–181. doi: 10.1016/s0002-9394(14)71282-6. [DOI] [PubMed] [Google Scholar]
  20. Stewart W. C., Cohen J. S., Netland P. A., Weiss H., Nussbaum L. L. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group. Am J Ophthalmol. 1997 Oct;124(4):498–505. doi: 10.1016/s0002-9394(14)70865-7. [DOI] [PubMed] [Google Scholar]
  21. Van Buskirk E. M., Bacon D. R., Fahrenbach W. H. Ciliary vasoconstriction after topical adrenergic drugs. Am J Ophthalmol. 1990 May 15;109(5):511–517. doi: 10.1016/s0002-9394(14)70679-8. [DOI] [PubMed] [Google Scholar]
  22. Viswanathan A. C., Fitzke F. W., Hitchings R. A. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997 Dec;81(12):1037–1042. doi: 10.1136/bjo.81.12.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zhao D. Y., Cioffi G. A. Anterior optic nerve microvascular changes in human glaucomatous optic neuropathy. Eye (Lond) 2000 Jun;14(Pt 3B):445–449. doi: 10.1038/eye.2000.129. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES